Kehua Bio-Science Receives Medical Device Registration Certificate for Neisseria Gonorrhoeae Nucleic Acid Detection Kit

中国证券报··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Kehua Bio-Science announced that the company recently received a medical device registration certificate from the National Medical Products Administration for its Neisseria gonorrhoeae nucleic acid detection kit, which uses PCR-fluorescence method. The certificate is valid from August 4, 2026 to August 3, 2031. The kit is used for in vitro qualitative detection of Neisseria gonorrhoeae nucleic acid in male urethral swab and female cervical swab samples. The company stated that the acquisition of this product enriches its product line and will have a positive impact on business development.

Impact on assets 1

Others▲ · 1 stocks
© 2026 MarketIVNews